We demonstrated a novel role of TGF-β in the induction of the MEC marker, SPOCK1, and the finding may suggest that alteration of the TGF-β pathway may be a potential cause of SPOCK1 dysregulation conferring poor prognosis in breast cancer. Here, TGFB1 is linked to breast carcinoma.